Table 2.

Associations with disease‐specific survival (hazard ratios and 95% confidence intervals)

		Hazard ratio	95% confidence interval	P value
Race/ethnicity	Asian/PI vs NH White	0.95	0.84‐1.06	0.3476
	Hispanic vs NH White	0.94	0.85‐1.04	0.2083
	NH Black vs NH White	1.21	1.09‐1.35	0.0004
Age	Per year	1.02	1.02‐1.02	<0.0001
FIGO stage	II vs I	2.21	1.92‐2.54	<0.0001
	III vs I	4.36	3.94‐4.82	<0.0001
	IV vs I	10.39	9.35‐11.55	<0.0001
	Unknown vs I	2.21	1.83‐2.67	<0.0001
Histologic subtype	Carcinosarcoma vs High‐grade endometrioid	1.88	1.72‐2.04	<0.0001
	Clear cell vs High‐grade endometrioid	0.99	0.85‐1.16	0.9180
	Mixed vs High‐grade endometrioid	0.68	0.61‐0.77	<0.0001
	Serous vs High‐grade endometrioid	1.09	0.99‐1.19	0.0745
Hysterectomy	No vs Yes	1.99	1.74‐2.27	<0.0001
Radiation	No vs Yes	1.04	0.97‐1.12	0.2565
Chemotherapy	No vs Yes	1.08	1.00‐1.17	0.0625
Charlson comorbidity score	1 vs 0	1.19	1.10‐1.30	<0.0001
	2+ vs 0	1.44	1.30‐1.61	<0.0001
	Unknown vs 0	0.97	0.84‐1.11	0.6388
Time to treatment	≤2 weeks vs 2‐4 weeks	1.14	1.03‐1.25	0.0076
	>4 weeks vs 2‐4 weeks	0.93	0.86‐1.02	0.1233
	No treatment vs 2‐4 weeks	2.07	1.71‐2.52	<0.0001
Primary payer	Medicare vs Private	1.09	1.01‐1.18	0.0304
	None vs Private	0.99	0.77‐1.27	0.9353
	Public/Medicaid, VA vs Private	1.06	0.95‐1.19	0.2705
	Unknown vs Private	0.99	0.81‐1.20	0.9053
Neighborhood SES	1 vs 5 (highest)	1.08	0.96‐1.22	0.1808
	2 vs 5 (highest)	1.06	0.96‐1.18	0.2417
	3 vs 5 (highest)	1.11	1.01‐1.23	0.0323
	4 vs 5 (highest)	1.00	0.91‐1.11	0.9389
Marital status	Not married vs Married	1.10	1.02‐1.18	0.0084
	Unknown vs Married	0.93	0.75‐1.15	0.4845
NCI cancer center	Yes vs No	0.88	0.79‐0.97	0.0110
Year of diagnosis	Per year	0.99	0.98‐1.00	0.2673

Statistically significant values are in bold.